Series D - IMPACT Therapeutics
Investment Firm
Overview
IMPACT Therapeutics is a therapeutics company dedicated to the development of similar drugs to treat cancer.
Announced Date
Mar 14, 2022
Closed on Date
Mar 14, 2022
Funding Type
Series D
Highlights
Location
Asia
Social
Investor Lead
N/A
Participant Investors
5
Round Details and Background
IMPACT Therapeutics raised an undisclosed amount on 2022-03-14 in Series D
IMPACT Therapeutics is a therapeutics company dedicated to the development of similar drugs to treat cancer.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 14, 2022 |  Series D - IMPACT Therapeutics | 9 | - | undefined |
| Apr 22, 2024 | Series D - IMPACT Therapeutics | 5 | - | 55.2M |
| Jul 07, 2014 | Series A - IMPACT Therapeutics | 3 | - | undefined |
| Feb 22, 2016 | Series B - IMPACT Therapeutics | 6 | - | 10.0M |
Recent Activity
There is no recent news or activity for this profile.